13F Data
13F filer · CIK 1471149

Ayer Capital Management, LP

SAN FRANCISCO, CA · filing since Q2 2013 · last filing Aug 14, 2015
Reported value
$26.8M
$-41.4M vs prior
Positions
2
New / sold out
0 / 0
Added / reduced
0 / 1
Turnover
0.0%
buys $0 · sells $25.5M
Top-10 weight
100.0%

Biggest buys vs Q1 2015

No new or increased positions this quarter.

Biggest sells vs Q1 2015

ChangeSecurityShares changeChange %Est. trade value
ReducedLION BIOTECHNOLOGIES INC-2,780,682-49.6%$-25.5M

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $16.9MQ3 2013: $18.4MQ4 2013: $4.4MQ1 2014: $0Q2 2014: $0Q1 2015: $68.3MQ2 2015: $26.8M
Q2 2013Q2 2015

Holdings · Q2 2015

#SecuritySharesValueWeight
1LION BIOTECHNOLOGIES INCCOM2,823,333$25.9M96.51%
2ONCOTHYREON INCCOM250,000$935.0K3.49%